# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Castleman's Disease

Angiofollicular ganglionic hyperplasia
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 13 results.
Sirolimus in Previously Treated Idiopathic Multicentric Castleman Disease
Status: Recruiting
Last Changed: Oct 03, 2019
First Received: May 01, 2019
Disease(s): Castleman Disease, Castleman's Disease, Multicentric
Intervention(s): Sirolimus
Locations: University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
University of Pennsylvania, Philadelphia, Pennsylvania, United States
BCD Regimen in Newly Diagnosed Idiopathic Multicentric Castleman's Disease (iMCD)
Status: Recruiting
Last Changed: Jun 12, 2019
First Received: Jun 12, 2019
Disease(s): Idiopathic Multicentric Castleman's Disease
Intervention(s): Bortezomib, Cyclophosphamide, Dexamethason
Locations: Peking Union Medical College Hospital, Beijing, Beijing, China
TCP Regimen in Newly Diagnosed MCD:a Prospective, Single-center, Single-arm, Phase-II Pilot Trial
Status: Recruiting
Last Changed: Feb 06, 2017
First Received: Feb 03, 2017
Disease(s): Multicentric Castleman Disease
Intervention(s): Thalidomide, cyclophosphamide and prednisone
Locations: Peking Union Medical College Hospital, Beijing, Beijing, China
Tocilizumab for KSHV-Associated Multicentric Castleman Disease
Status: Recruiting
Last Changed: Nov 28, 2019
First Received: Sep 27, 2011
Disease(s): Castleman Disease, Castleman's Disease, Giant Lymph Node Hyperplasia
Intervention(s): Zidovudine, Tocilizumab, Valganciclovir (VGC)
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Unlock the Cell: Castleman's Disease Flow Cytometry Study
Status: Recruiting
Last Changed: Aug 03, 2018
First Received: Aug 03, 2016
Disease(s): Castleman Disease, Angiofollicular Lymphoid Hyperplasia, GLNH, Hyperplasia, Castleman's Disease, Angiofollicular Lymph Hyperplasia, Giant Lymph Node Hyperplasia
Intervention(s): Blood draw/buccal swab
Locations: University of Pennsylvania, Philadelphia, Pennsylvania, United States
International Registry for Patients With Castleman Disease
Status: Recruiting
Last Changed: Aug 27, 2019
First Received: Jun 29, 2016
Disease(s): Castleman Disease, Castleman's Disease, Giant Lymph Node Hyperplasia, Angiofollicular Lymph Hyperplasia, Angiofollicular Lymph Node Hyperplasia, Angiofollicular Lymphoid Hyperplasia, GLNH, Hyperplasia, Giant Lymph Node, Lymph Node Hyperplasia, Giant
Locations: University of Pennsylvania, Philadelphia, Pennsylvania, United States
Hopital Cl Huriez, Lille, Nord, France
Hopital Saint-Louis, Paris, France
Universitätsklinikum Münster, Munster, NRW, Germany
Infektionsmedizinisches Centrum, Hamburg, Germany
... and 6 other locations.
Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease
Status: Recruiting
Last Changed: Nov 04, 2019
First Received: Oct 04, 2017
Disease(s): Human Immunodeficiency Virus, Castleman's Disease, Kaposi's Sarcoma, Viral-Associated Cancer
Locations: National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Rituximab Hyaluronidase in Combination With Chemotherapy in Treating Aggressive B-cell Lymphoma in Uganda
Status: Recruiting
Last Changed: Dec 09, 2019
First Received: Mar 06, 2019
Disease(s): Burkitt Lymphoma, KSHV-associated Multicentric Castleman Disease, Diffuse Large B-Cell Lymphoma
Intervention(s): Rituximab or Rituximab Hyaluronidase Human, Cyclophosphamide, Vincristine, Methotrexate, Doxorubicin, Doxorubicin Hydrochloride, Prednisone, Etoposide
Locations: Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity
Status: Recruiting
Last Changed: Dec 03, 2019
First Received: Sep 22, 2004
Disease(s): Lymphoproliferative Disorder, HHV-8, Malignancy, HIV
Intervention(s): Etoposide, Interferon-alpha, Rituximab, Zidovudine, Liposomal Doxorubicin, Bortezomib, Valganciclovir, Doxorubicin, Vincristine, Cyclophosphamide, Filgrastim (G-CSF), Prednisone, Sirolimus, Observation Only
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Specimen Collections From Patients With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
Status: Recruiting
Last Changed: Nov 19, 2019
First Received: Nov 23, 2000
Disease(s): HIV, Kaposi's Sarcoma, Lymphomas, Multicentric Castleman's Disease, Primary Effusion Lymphoma
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States